| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.012 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |